Antibacterial activity of Stenotrophomonas maltophilia endolysin P28 against both gram-positive and gram-negative bacteria

Frontiers in Microbiology

Volumn 6, Issue NOV, 2015, Pages

  Dong, Hongling ^a   Zhu, Chaoyang ^a   Chen, Jingyi ^a   Ye, Xing ^a   Huang, Yu Ping ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Hubei Provincial Cooperative Innovation Center of Industrial Fermentation   (China)

Author keywords

Antibacterial activity; EDTA; Endolysin; Maltocin; Stenotrophomonas maltophilia

Indexed keywords

BACTERIOCIN; ENDOLYSIN P28; UNCLASSIFIED DRUG;

ACIDITY; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; ENZYME ACTIVITY; KLEBSIELLA PNEUMONIAE; MOLECULAR CLONING; PH; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SALINITY; SEQUENCE ANALYSIS; SHIGELLA FLEXNERI; STENOTROPHOMONAS MALTOPHILIA; THERMOSTABILITY; XANTHOMONAS CITRI; XANTHOMONAS MALVACEARUM;

EID: 84949782601     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01299     Document Type: Article

References (40)

1. Blackburn, N. T., and Clarke, A. J. (2001). Identification of four families of peptidoglycan lytic transglycosylases. J. Mol. Evol. 52, 78-84. doi: 10.1007/s002390010136
2. Bragg, R., van der Westhuizen, W., Lee, J. Y., Coetsee, E., and Boucher, C. (2014). Bacteriophages as potential treatment option for antibiotic resistant bacteria. Adv. Exp. Med. Biol. 807, 97-110. doi: 10.1007/978-81-322-1777-0_7
3. Briers, Y., Volckaert, G., Cornelissen, A., Lagaert, S., Michiels, C. W., Hertveldt, K., et al. (2007). Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL. Mol. Microbiol. 65, 1334-1344. doi: 10.1111/j.1365-2958.2007.05870.x
4. Briers, Y., Walmagh, M., and Lavigne, R. (2011). Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa. J. Appl. Microbiol. 110, 778-785. doi: 10.1111/j.1365-2672.2010.04931.x
5. Brooke, J. S. (2012). Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25, 2-41. doi: 10.1128/CMR.00019-11
6. Callewaert, L., Walmagh, M., Michiels, C. W., and Lavigne, R. (2011). Food applications of bacterial cell wall hydrolases. Curr. Opin. Biotechnol. 22, 164-171. doi: 10.1016/j.copbio.2010.10.012
7. Coffey, B., Mills, S., Coffey, A., McAuliffe, O., and Ross, R. P. (2010). Phage and their lysins as biocontrol agents for food safety applications. Annu. Rev. Food Sci. Technol. 1, 449-468. doi: 10.1146/annurev.food.102308.124046
8. During, K., Porsch, P., Mahn, A., Brinkmann, O., and Gieffers, W. (1999). The non-enzymatic microbicidal activity of lysozymes. FEBS Lett. 449, 93-100. doi: 10.1016/S0014-5793(99)00405-6
9. Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K., and Dimopoulos, G. (2009). Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur. J. Clin. Microbiol. Infect. Dis. 28, 719-730. doi: 10.1007/s10096-009-0709-5
10. Farris, M. H., and Steinberg, A. D. (2014). Mitrecin A, an endolysin-like bacteriolytic enzyme from a newly isolated soil streptomycete. Lett. Appl. Microbiol. 58, 493-502. doi: 10.1111/lam.12220
11. Fischetti, V. A. (2008). Bacteriophage lysins as effective antibacterials. Curr. Opin. Microbiol. 11, 393-400. doi: 10.1016/j.mib.2008.09.012
12. Fischetti, V. A. (2010). Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int. J. Med. Microbiol. 300, 357-362. doi: 10.1016/j.ijmm.2010.04.002
13. Fokine, A., Miroshnikov, K. A., Shneider, M. M., Mesyanzhinov, V. V., and Rossmann, M. G. (2008). Structure of the bacteriophage phi KZ lytic transglycosylase gp144. J. Biol. Chem. 283, 7242-7250. doi: 10.1074/jbc. M709398200
14. Gilmer, D. B., Schmitz, J. E., Euler, C. W., and Fischetti, V. A. (2013). Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57, 2743-2750. doi: 10.1128/AAC.02526-12
15. Grandgirard, D., Loeffler, J. M., Fischetti, V. A., and Leib, S. L. (2008). Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J. Infect. Dis. 197, 1519-1522. doi: 10.1086/587942
16. Guzoglu, N., Demirkol, F. N., and Aliefendioglu, D. (2015). Haemorrhagic pneumonia caused by Stenotrophomonas maltophilia in two newborns. J. Infect. Dev. Ctries. 18, 533-535. doi: 10.3855/jidc.5463
17. Hotta, G., Matsumura, Y., Kato, K., Nakano, S., Yunoki, T., Yamamoto, M., et al. (2014). Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PLoS ONE 9:e112208. doi: 10.1371/journal.pone.0112208
18. Jespers, L., Sonveaux, E., and Fastrez, J. (1992). Is the bacteriophage lambda lysozyme an evolutionary link or a hybrid between the C and V-type lysozymes? Homology analysis and detection of the catalytic amino acid residues. J. Mol. Biol. 228, 529-538. doi: 10.1016/0022-2836(92)90840-G
19. Lai, M. J., Lin, N. T., Hu, A. R., Soo, P. C., Chen, L. K., Chen, L. H., et al. (2011). Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria. Appl. Microbiol. Biotechnol. 90, 529-539. doi: 10.1007/s00253-011-3104-y
20. Lim, J. A., Shin, H., Heu, S., and Ryu, S. (2014). Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria. J. Microbiol. Biotechnol. 24, 803-811.
21. Lim, J. A., Shin, H., Kang, D. H., and Ryu, S. (2012). Characterization of endolysin from a Salmonella Typhimurium-infecting bacteriophage SPN1S. Res. Microbiol. 163, 233-241. doi: 10.1016/j.resmic.2012.01.002
22. Liu, J., Chen, P., Zheng, C., and Huang, Y. P. (2013). Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia. Appl. Environ. Microbiol. 79, 5593-5600. doi: 10.1128/AEM.01648-13
23. Loessner, M. J. (2005). Bacteriophage endolysins-current state of research and applications. Curr. Opin. Microbiol. 8, 480-487. doi: 10.1016/j.mib.2005.06.002
24. Looney, W. J., Narita, M., and Muhlemann, K. (2009). Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9, 312-323. doi: 10.1016/S1473-3099(09)70083-0
25. Lukacik, P., Barnard, T. J., Hinnebusch, B. J., and Buchanan, S. K. (2013). Specific targeting and killing of Gram-negative pathogens with an engineered phage lytic enzyme. Virulence 4, 90-91. doi: 10.4161/viru.22683
26. Lukacik, P., Barnard, T. J., Keller, P. W., Chaturvedi, K. S., Seddiki, N., Fairman, J., et al. (2012). Structural engineering of a phage lysin that targets Gram-negative pathogens. Proc. Natl. Acad. Sci. U.S.A. 109, 9857-9862. doi: 10.1073/pnas.1203472109
27. Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593-656. doi: 10.1128/MMBR.67.4.593-656.2003
28. Oey, M., Lohse, M., Scharff, L. B., Kreikemeyer, B., and Bock, R. (2009). Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc. Natl. Acad. Sci. U.S.A. 106, 6579-6584. doi: 10.1073/pnas.0813146106
29. Oliveira, H., Thiagarajan, V., Walmagh, M., Sillankorva, S., Lavigne, R., Neves-Petersen, M. T., et al. (2014). A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against Gram-Negative pathogens in presence of weak acids. PLoS ONE 9:e108376. doi: 10.1371/journal.pone.0108376
30. Orito, Y., Morita, M., Hori, K., Unno, H., and Tanji, Y. (2004). Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis. Appl. Microbiol. Biot. 65, 105-109. doi: 10.1007/s00253-003-1522-1
31. Rodriguez, L., Martinez, B., Zhou, Y., Rodriguez, A., Donovan, D. M., and Garcia, P. (2011). Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol. 11:138. doi: 10.1186/1471-2180-11-138
32. Sambrook, J. (1989). Molecular Cloning: A Laboratory Manual [M], 3rd Edn. New York, NY: Cold Spring Harbor Laboratory.
33. Sánchez, M. B. (2015). Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front. Microbiol. 6:658. doi: 10.3389/fmicb.2015.00658
34. Schmelcher, M., Donovan, D. M., and Loessner, M. J. (2012). Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 7, 1147-1171. doi: 10.2217/fmb.12.97
35. Schmitz, J. E., Schuch, R., and Fischetti, V. A. (2010). Identifying active phage lysins through functional viral metagenomics. Appl. Environ. Microbiol. 76, 7181-7187. doi: 10.1128/AEM.00732-10
36. Sood, S., Vaid, V. K., and Bhartiya, H. (2013). Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure. J. Clin. Diagn. Res. 7, 1696-1697. doi: 10.7860/JCDR/2013/5614.3248
37. Tan, C. K., Liaw, S. J., Yu, C. J., Teng, L. J., and Hsueh, P. R. (2008). Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn. Microbiol. Infect. Dis. 60, 205-210. doi: 10.1016/j.diagmicrobio.2007.09.007
38. Trignano, E., Manz, M. J., Fallico, N., Maffei, M., Marongiu, F., Campus, G. V., et al. (2014). First report of digital skin ulcer with Stenotrophomonas maltophilia infection in an immunocompetent patient. In Vivo 28, 259-261.
39. Walmagh, M., Boczkowska, B., Grymonprez, B., Briers, Y., Drulis-Kawa, Z., and Lavigne, R. (2013). Characterization of five novel endolysins from Gram-negative infecting bacteriophages. J. Microbiol. Biotechnol. 97, 4369-4375. doi: 10.1007/s00253-012-4294-7
40. Yang, H., Yu, J., and Wei, H. (2014). Engineered bacteriophage lysins as novel anti-infectives. Front. Microbiol. 5:542. doi: 10.3389/fmicb.2014.00542